- The rhythm of Eli Lilly’s earnings is darkened by Novo News. What it means for investors CNBC
- Eli Lilly Stock Slips despite the fact that the profits beat, reaffirmed in 2025 Yahoo Finance
- Eli Lilly returned to the request for Mounjaro, other weight loss drugs Wsj
- Lilly reports the financial results of the first quarter of 2025 and highlights the momentum of the pipeline Eli Lilly and Company
- The Eli Lilly gains have beaten expectations. Why the stock drops. Barron
The rhythm of Eli Lilly’s earnings is darkened by Novo News. What it means for investors – CNBC
